U.S. FDA approved second OTC Naloxone nasal spray product
On Jul. 28, 2023, the U.S. FDA approved RiVive, 3 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter…
On Jul. 28, 2023, the U.S. FDA approved RiVive, 3 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter…
On Jul. 28, 2023, researchers from the Institute of Zoology at the University of Cologne, the Max Planck…
On Jul. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $50.1 million to fund clinical-stage research…
On Jul. 27, 2023, the IHR National Focal Point of Poland notified WHO of unusual deaths in cats…
On Jul. 27, 2023, the Centers for Disease Control and Prevention (CDC) reported that between 2010 and 2022,…
On Jul. 27, 2023, SIGA Technologies announced that the U.S. Department of Health and Human Services exercised procurement…
On Jul. 25, 2023, U.S. National Science Foundation-supported research, led by Joshua Rosenthal of the Marine Biological Laboratory…
Milestones in Diabetes illustrates major milestones from the first administration of the hormone insulin in 1921 to a…
On Jul. 24, 2023, the Journal JAMA reported there is evidence that Republican-leaning counties had higher COVID-19 death…
On Jul. 24, 2023, the United Arab Emirates (UAE), notified WHO of a case of Middle East Respiratory…
On Jul. 20, 2023, seven innovative pharmaceutical companies announced they had established the INTREPID Alliance, with the goal…
On Jul. 20, 2023, Emergent BioSolutions announced that the U.S. Food and Drug Administration (FDA) had approved CYFENDUSï¾™…
On Jul. 19, 2023, a team of scientists from the Translational Genomics Research Institute (TGen), part of the…
On Jul. 19, 2023, the National Institute of Health announced that a nationwide research team had created the…
On Jul. 19, 2023, the King County Department of Health issued a Health Advisory that Candida auris (C….
On Jul. 18, 2023, scientists reported that they had extracted, sequenced, and analyzed historical RNA from muscle and…
On Jul. 17, 2023, the FDA approved AstraZeneca’s Beyfortus (nirsevimab-alip) for the prevention of Respiratory Syncytial Virus (RSV)…
On Jul. 14, 2023, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) had approved a…
On Jul. 14, 2023, the UK Animal and Plant Health Agency reported that additional asymptomatic human detections of…
On Jul. 13, 2023, the Centers for Disease Control and Prevention (CDC) announced the launch of the Bridge…
On Jul. 13, 2023, Perrigo announced that the U.S. Food and Drug Administration had approved Opill, a progestin-only…
On Jul. 10, 2023, a report published in the journal Nature detailed frequent spillovers of SARS-CoV-2 from humans…
On Jul. 6, 2023, Eisai and Biogen announced that the U.S. Food and Drug Administration (FDA) has approved…
On Jul. 6, 2023, University of Illinois Urbana-Champaign researchers reported they can detect exposure to the SARS-CoV-2 virus…
On Jul. 5, 2023, the IHR National Focal Point of Poland notified WHO of unusual deaths in cats…
On Jun. 29, 2023, the Centers for Disease Control and Prevention (CDC) endorsed the CDC Advisory Committee on…
On Jun. 29, 2023, the U.S. Food and Drug Administration approved Roctavian, an adeno-associated virus vector-based gene therapy…
On Jun. 27, 2023, the Centers for Disease Control and Prevention (CDC) adopted the 2023-2024 Advisory Committee on…
On Jun. 26, 2023, the Centers for Disease Control and Prevention (CDC) announced they were collaborating with U.S….
On Jun. 26, 2023, Jaguar Health announced that the Take C.H.A.R.G.E. (Canine Health And ReGistry Exchange) had joined…